In vivo hepatoprotective activity of the aqueous extract of Artemisia absinthium L. against chemically and immunologically induced liver injuries in mice

Journal of Ethnopharmacology

Volumn 131, Issue 2, 2010, Pages 478-484

  Amat, Nurmuhammat ^a   Upur, Halmurat ^a   Blažeković, Biljana ^b  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Artemisia absinthium L.; BCG LPS; CCl4; Hepatoprotective effect; Phenolic constituents; TNF

Indexed keywords

ALANINE AMINOTRANSFERASE; ARTEMISIA ABSINTHIUM EXTRACT; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; ENDOTOXIN; FLAVONOID; GLUTATHIONE PEROXIDASE; INTERLEUKIN 1; MALONALDEHYDE; PHENOL; PHENOLIC ACID; SESQUITERPENE LACTONE; SUPEROXIDE DISMUTASE; TANNIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTEMISIA ABSINTHIUM; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; IN VIVO STUDY; LIPID PEROXIDATION; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PHYTOCHEMISTRY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETRY; THIN LAYER CHROMATOGRAPHY;

ALANINE TRANSAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ARTEMISIA ABSINTHIUM; ASPARTATE AMINOTRANSFERASES; CARBON TETRACHLORIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; IMMUNE SYSTEM; INFLAMMATION; INTERLEUKIN-1; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED STRAINS; NECROSIS; PHYTOTHERAPY; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA;

ARTEMISIA ABSINTHIUM; MUS;

EID: 77956263853     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.07.023     Document Type: Article

References (37)

1. Bergamini C.M., Gambetti S., Dondi A., Cervellati C. Oxygen, reactive oxygen species and tissue damage. Current Pharmaceutical Design 2004, 10:1611-1626.
2. Canadanovic-Brunet J.M., Djilas S.M., Cetkovic G.S., Tumbas V.T. Free-radical scavenging activity of wormwood (Artemisia absinthium L.) extracts. Journal of the Science of Food and Agriculture 2005, 85:265-272.
3. Caner A., Doskaya M., Degirmenci A., Can H., Baykan S., Uner A., Basdemir G., Zeybek U., Guruz Y. Comparison of the effects of Artemisia vulgaris and Artemisia absinthium growing in western Anatolia against trichinellosis (Trichinella spiralis) in rats. Experimental Parasitology 2008, 119:173-179.
4. Castro L., Freeman B.A. Reactive oxygen species in human health and disease. Nutrition 2001, 17:161-165.
5. Cesaratto L., Vascotto C., Calligaris S., Tell G. The importance of redox state in liver damage. Annals of Hepatology 2004, 3:86-92.
6. Chaterrjee T.K. Medicinal plants with hepatoprotective properties. Herbal Options 2000, 155. Calcutta: Books & Allied Ltd, Calcuta. third ed. T.K. Chaterrjee (Ed.).
7. Chinese Pharmacopoeia Uighur Medicines 2005, China Chemical Industry Press, Beijing, pp. 181-182.
8. Corazza N., Badmann A., Lauer C. Immune cell-mediated liver injury. Seminars in Immunopathology 2009, 31:267-277.
9. European Pharmacopoeia European Pharmacopoeia 2004, Council of Europe, Strasbourg, pp. 187. fourth ed.
10. European Pharmacopoeia European Pharmacopoeia 2004, Council of Europe, Strasbourg, p. 676. fourth ed.
11. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991, 11:81-128.
12. 4-induced hepatotoxicity. General Pharmacology 1995, 26:309-315.
13. Hoffmann B., Herrmann K. Flavonol glycosides of mugwort (Artemisia vulgaris), tarragon (Artemisia dranunculus) and absinthe (Artemisia absinthium). Zeitschrift für Lebensmittel-Untersuchung und -Forschung A 1982, 174:211-215.
14. Jaeschenke H. Reactive oxygen and mechanisms of inflammatory liver injury. Journal of Gastroenterology and Hepatology 2000, 15:718-724.
15. Jamshidzadeh A., Fereidooni F., Salehi Z., Niknahad H. Hepatoprotective activity of Gundelia tournefortii. Journal of Ethnopharmacology 2005, 101:233-237.
16. 4-induced hepatotoxicity in rodents. Fitoterapia 2002, 73:557-563.
17. Janbaz K.H., Saeed S.A., Gilani A.H. Studies on the protective effects of caffeic acid and quercetin on chemical-induced hepatotoxicity in rodents. Phytomedicine 2004, 11:424-430.
18. Jurišić Grubešić R., Vuković J., Kremer D., Vladimir-Knežević S. Flavonoid content assay: prevalidation and application on Plantago L. species. Acta Chimica Slovenica 2007, 54:397-406.
19. Kapil A., Koul I.B., Suri O.P. Antihepatotoxic effects of chlorogenic acid from Anthocephalus cadamba. Phytotherapy Research 1995, 9:189-193.
20. Kew M.C. Serum aminotransferase concentration as evidence of hepatocellular damage. Lancet 2000, 355:591-592.
21. Kuntz E., Kuntz H.D. Hepatology: History, Morphology, Biochemistry, Diagnostics, Clinic, Therapy 2005, Birkhäuser, Heidelberg, pp. 52-53.
22. Lee H.G., Kim H., Oh W.K., Yu K.A., Choe Y.K., Ahn J.S., Kim D.S., Kim S.H., Dinarello C.A., Kim K., Yoon D.Y. Tetramethoxy hydrodyflavone p7F downregulates inflammatory mediators via the inhibition of nuclear factor κB. Annals of the New York Academy of Sciences 2004, 1030:555-568.
23. Malhi H., Gores G.J. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008, 134:1641-1654.
24. Muto T., Watanabe T., Okamura M., Moto M., Kashida Y., Mitsumori K. Thirteen-week repeated dose toxicity study of wormwood (Artemisia absinthium) extract in rats. Journal of Toxicological Sciences 2003, 28:471-478.
25. Muto Y., Nouri-Aria K.T., Meager A., Alexander G.J., Eddleston A.L., Williams R. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988, 2:72-74.
26. Nagai H., Yakuo I., Yamada H., Shimazawa T., Koda A., Niu K., Asano K., Shimizu T., Kasahara M. Liver injury model in mice for immunopharmacological study. The Japanese Journal of Pharmacology 1988, 46:247-254.
27. Nagakawa J., Hishinuma I., Hirota K., Hirota K., Miyamoto K., Yamanaka T., Tsukidate K., Katayama K., Yamatsu I. Involvement of tumor necrosis factor-α in the pathogenesis of activated macrophage-mediated hepatitis in mice. Gastroenterology 1990, 99:758-765.
28. Naveau S., Balian A., Capron F., Raynard B., Fallik D., Agostini H., Grangeot-Keros L., Portier A., Galanaud P., Chaput J.C., Emilie D. Balance between pro and anti-inflammatory cytokines in patients with acute alcoholic hepatitis. Gastroentérologie Clinique et Biologique 2005, 29:269-274.
29. 4 induced hepatic damage in rats. Journal of Ethnopharmacology 2010, 127:777-780.
30. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. The FASEB Journal 2008, 22:659-661.
31. Tacke F., Luedde T., Trautwein C. Inflammatory pathways in liver homeostasis and liver injury. Clinical Reviews in Allergy and Immunology 2009, 36:4-12.
32. Tegtmeier M., Harnischfeger G. Methods for the reduction of thujone content in pharmaceutical preparations of Artemisia Salvia and Thuja. European Journal of Pharmaceutics and Biopharmaceutics 1994, 40:337-340.
33. Upur H., Amat N., Blažeković B., Talip A. Protective effect of Cichorium glandulosum root extract on carbon tetrachloride-induced and galactosamine-induced hepatotoxicity in mice. Food and Chemical Toxicology 2009, 8:2022-2030.
34. Wagner H., Bladt S., Zgainski E.M. Drogenanalyse 1983, Springer Verlag, Berlin, pp. 125-173.
35. Weber L.W., Boll M., Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Critical Reviews in Toxicology 2003, 33:105-136.
36. Wichtl M. Herbal Drugs and Phytopharmaceuticals 1994, Medpharm Scientific Publishers, Stuttgart, pp. 45-48. first ed.
37. Zou Y., Yang Y., Li J., Li W., Wu Q. Prevention of hepatic injury by a traditional Chinese formulation, BJ-JN, in mice treated with Bacille-Calmette-Guérin and lipopolysaccharide. Journal of Ethnopharmacology 2006, 107:442-448.